Skip to main content
logo
Kairos Pharma, Ltd. (KAPA)
NYSEAMERICAN: KAPA · Real-Time Price · USD
0.8700
-0.2800 (-24.35%)
At close: Oct 7, 2026, 4:00 PM
0.9300
+0.0600 (6.90%)
After-hours: Oct 7, 2026, 7:49 PM EDT

Kairos Pharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
31520---
Market Cap Growth
-88.82%-24.29%----
Enterprise Value
0916---
Last Close Price
1.154.9710.64---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
0.842.334.09---
P/TBV Ratio
0.702.354.29---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
----0.31-0.50-0.34
Net Debt / Equity Ratio
-0.63-0.71-0.27-0.26-0.13-0.28
Net Debt / EBITDA Ratio
0.450.830.58-0.35-0.36-0.17
Quick Ratio
9.9122.571.280.040.270.04
Current Ratio
11.9827.074.200.040.270.04
Return on Equity (ROE)
-113.96%-97.99%-192.96%---
Return on Assets (ROA)
-66.91%-56.59%-43.50%-107.07%-39.41%-307.71%
Return on Capital Employed (ROCE)
-142.10%-87.90%-49.10%119.00%95.60%166.50%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-197.10%-36.85%-13.33%---
Buyback Yield / Dilution
-46.73%-62.27%-9.38%-1.42%-11.86%3.12%
SEC Filings: 10-K · 10-Q